Quest Diagnostics Clinical Laboratories Inc is categorized under Pathological Laboratories in Loma Linda, CA .
Quest Diagnostics Clinical Laboratories Inc was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Pathological Laboratories business, which does work in the B2C market, and is classified as a Pathological Laboratories, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact Geoffrey O'connor at the company’s branch by writing to 11370 Anderson St, Loma Linda, California CA 92354 or by phoning (909) 824-7721. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Quest Diagnostics Clinical Laboratories Inc |
| Contact Person: | Geoffrey O'connor |
| Address: | 11370 Anderson St, Loma Linda, California 92354 |
| Phone Number: | (909) 824-7721 |
| Annual Revenue (USD): | Unknown |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Pathological Laboratories |
| SIC Code: | 8071 |
| NAICS Code: | 621511 |
| Share This Business: |
Quest Diagnostics Clinical Laboratories Inc was started in 0 to provide professional Pathological Laboratories under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Geoffrey O'connor for inquiries that concern Quest Diagnostics Clinical Laboratories Inc by calling the company number (909) 824-7721, as your correspondence is most welcome. Additionally, the physical location of the branch of Quest Diagnostics Clinical Laboratories Inc can be found at the coordinates 34.046655,-117.261284 as well as the street address 11370 Anderson St in Loma Linda, California 92354.
For its online presence, you may visit Quest Diagnostics Clinical Laboratories Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.